11 – 20 of 2254
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
When is ABO-incompatible plasma safe to transfuse? : Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products
2025) In Blood Transfusion(
- Contribution to journal › Scientific review
-
Mark
Second- and Third-Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML—A Population-Based Study
2025) In European Journal of Haematology(
- Contribution to journal › Article
-
Mark
Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition : Results from a Prospective Cohort Study
(
- Contribution to journal › Article
-
Mark
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis
(
- Contribution to journal › Article
-
Mark
Medium-dose irradiation impairs long-term hematopoietic stem cell functionality and hematopoietic resilience to cytotoxic stress
(
- Contribution to journal › Article
-
Mark
Metachromatic Leukodystrophy : New Therapy Advancements and Emerging Research Directions
(
- Contribution to journal › Scientific review
-
Mark
Platelet transfusion practice in the intensive care unit : the Nine-I international platelet transfusion survey
(
- Contribution to journal › Article
-
Mark
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
(
- Contribution to journal › Article
-
Mark
A non-genotoxic stem cell therapy boosts lymphopoiesis and averts age-related blood diseases in mice
(
- Contribution to journal › Article
-
Mark
Peripheral T- and natural killer-cell lymphomas : ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
(
- Contribution to journal › Article